Jegerlehner Sabrina, Bulliard Jean-Luc, Aujesky Drahomir, Rodondi Nicolas, Germann Simon, Konzelmann Isabelle, Chiolero Arnaud
Division of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Division of Chronic Diseases, IUMSP, Lausanne University Hospital, Lausanne, Switzerland.
PLoS One. 2017 Jun 14;12(6):e0179387. doi: 10.1371/journal.pone.0179387. eCollection 2017.
The increase in incidence of thyroid cancer during the last decades without concomitant rise in mortality may reflect the growing detection of indolent forms of thyroid cancer, and may have fueled unnecessary thyroidectomies. Our aim was therefore, to compare recent secular trends in surgical intervention rate for thyroid cancer with the incidence and mortality of thyroid cancer to assess overdiagnosis and resulting overtreatment.
We conducted a population-based temporal trend study in Switzerland from 1998 to 2012. All cases of invasive thyroid cancer, deaths from thyroid cancer, and cancer-related thyroidectomies were analyzed. We calculated changes in age-standardized thyroid cancer incidence rates, stratified by histologic subtype and tumor stage, thyroid cancer-specific mortality, and thyroidectomy rates.
Between 1998 and 2012, the age-standardized annual incidence of thyroid cancer increased from 5.9 to 11.7 cases/100,000 among women (annual mean absolute increase: +0.43/100,000/year) and from 2.7 to 3.9 cases/100,000 among men (+0.11/100,000/year). The increase was limited to the papillary subtype, the most indolent form of thyroid cancer. The incidence of early stages increased sharply, the incidence of advanced stages increased marginally, and the mortality from thyroid cancer decreased slightly. There was a three- to four-fold increase in the age-standardized annual thyroidectomy rate in both sexes.
We observed a large increase in the incidence of thyroid cancer, limited to papillary and early stage tumors, with a three- to four-fold parallel increase in thyroidectomy. The mortality slightly decreased. These findings suggest that a substantial and growing part of the detected thyroid cancers are overdiagnosed and overtreated.
Targeted screening and diagnostic strategies are warranted to avoid overdetection and unnecessary treatment of thyroid cancers.
过去几十年间甲状腺癌发病率上升,但死亡率并未随之增加,这可能反映出惰性甲状腺癌的检出率不断提高,也可能导致了不必要的甲状腺切除术。因此,我们的目的是比较甲状腺癌手术干预率的近期长期趋势与甲状腺癌的发病率和死亡率,以评估过度诊断及由此导致的过度治疗情况。
我们在瑞士开展了一项基于人群的时间趋势研究,时间跨度为1998年至2012年。分析了所有侵袭性甲状腺癌病例、甲状腺癌死亡病例以及与癌症相关的甲状腺切除术。我们计算了按组织学亚型和肿瘤分期分层的年龄标准化甲状腺癌发病率变化、甲状腺癌特异性死亡率以及甲状腺切除术率。
1998年至2012年间,女性年龄标准化的甲状腺癌年发病率从每10万人5.9例增至11.7例(年平均绝对增加量:+0.43/10万/年),男性从每10万人2.7例增至3.9例(+0.11/10万/年)。发病率的增加仅限于乳头状亚型,这是甲状腺癌中最惰性的形式。早期阶段的发病率急剧上升,晚期阶段的发病率略有上升,而甲状腺癌死亡率略有下降。两性的年龄标准化年甲状腺切除术率均增加了三到四倍。
我们观察到甲状腺癌发病率大幅上升,仅限于乳头状和早期肿瘤,同时甲状腺切除术平行增加了三到四倍。死亡率略有下降。这些发现表明,检测到的甲状腺癌中有相当一部分且数量不断增加的病例被过度诊断和过度治疗。
有必要采取针对性的筛查和诊断策略,以避免甲状腺癌的过度检测和不必要的治疗。